Evonik has announced a 10% net price increase for MetAMINO® (DL-methionine 99%, feed grade), effective immediately across all markets. The company confirmed that all existing contracts and supply agreements will continue to be honoured.
MetAMINO® is part of the company’s Advanced Technologies segment, which includes feed ingredients alongside high-performance polymers, crosslinking agents, hydrogen peroxide, and silica. In 2025, this segment generated €5.9 billion in sales with around 9,200 employees.
Evonik, headquartered in Essen, Germany, operates in more than 100 countries. In 2025, the company reported €14.1 billion in total sales and an adjusted EBITDA of €1.9 billion.
